Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.

BACKGROUND: When treatment-refractory schizophrenia shows an insufficient response to a trial of clozapine, clinicians commonly add a second antipsychotic, despite the lack of robust evidence to justify this practice. OBJECTIVES: The main objectives of the study were to establish the clinical effect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Health Technol Assess
Hauptverfasser: Barnes, Thomas Re, Leeson, Verity C, Paton, Carol, Marston, Louise, Davies, Linda, Whittaker, William, Osborn, David, Kumar, Raj, Keown, Patrick, Zafar, Rameez, Iqbal, Khalid, Singh, Vineet, Fridrich, Pavel, Fitzgerald, Zachary, Bagalkote, Hemant, Haddad, Peter M, Husni, Mariwan, Amos, Tim
Format: Artigo
Sprache:Inglês
Veröffentlicht: NIHR Journals Library 2017
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5601255/
https://ncbi.nlm.nih.gov/pubmed/28869006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta21490
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge